Avita Medical Inc. (RCEL) — Financial statements
Income statement, balance sheet, and cash flow for Avita Medical Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 72↑11.5% | 64↑28.1% | 50↑45.7% | 34↑4.2% | 33 | |
| Cost of Revenue | 13↑40.7% | 9↑16.9% | 8↑28.8% | 6↓1.0% | 6 | |
| Gross Profit | 59↑6.6% | 55↑30.2% | 42↑49.3% | 28↑5.4% | 27 | |
| Operating Expenses | ||||||
| R&D Expenses | 21↑2.4% | 20↓2.2% | 21↑50.3% | 14↓11.6% | 16 | |
| General & Administrative Expenses | 27↓17.5% | 33↑17.2% | 28↑21.4% | 23↑11.4% | 21 | |
| Selling & Marketing Expenses | 53↓9.7% | 58↑56.1% | 37↑70.2% | 22↑34.7% | 16 | |
| SG&A Expenses | 80↓12.6% | 91↑39.3% | 66↑45.1% | 45↑21.6% | 37 | |
| Other Expenses | 0.00 | 0.00↑100.0% | -1↑55.6% | -3↓281.4% | -0.84 | |
| Operating Expenses | 101↓9.8% | 112↑31.4% | 85↑52.1% | 56↑7.4% | 52 | |
| Total Costs & Expenses | 114↓6.0% | 121↑30.2% | 93↑49.9% | 62↑6.5% | 58 | |
| Operating Results | ||||||
| Operating Income | -42↑25.9% | -57↓32.7% | -43↓55.1% | -28↓9.5% | -25 | |
| Depreciation & Amortization | 2↑108.4% | 1↑78.2% | 0.63↑11.3% | 0.57↓15.6% | 0.67 | |
| EBITDA | -40↑28.4% | -55↓64.9% | -34↓28.8% | -26↓6.7% | -24 | |
| EBIT | -42↑25.7% | -56↓65.1% | -34↓28.4% | -27↓6.1% | -25 | |
| Interest & Other Income | ||||||
| Net Interest Income | -5↑6.7% | -5↓369.0% | -1↓4963.4% | 0.02↑181.0% | -0.03 | |
| Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 0.02 | 0.00 | |
| Interest Expense | 5↓6.7% | 5↑369.0% | 1↑7043.8% | 0.02↓44.8% | 0.03 | |
| Non-Operating Income | 0.00↑100.0% | -0.16↑98.1% | -8↓851.0% | -0.89↓2023.8% | -0.04 | |
| Other Income / Expenses | -7↓27.8% | -5↓170.8% | 7↑737.9% | 0.88↑4766.7% | 0.02 | |
| Income Before Tax | -49↑21.4% | -62↓75.0% | -35↓32.6% | -27↓6.1% | -25 | |
| Income Tax Expense | 0.01↓79.6% | 0.05↓18.2% | 0.07↑83.3% | 0.04↓14.3% | 0.04 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -49↑21.4% | -62↓74.8% | -35↓32.7% | -27↓6.1% | -25 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -49↑21.4% | -62↓74.8% | -35↓32.7% | -27↓6.1% | -25 | |
| Bottom-Line Net Income | -49↑21.4% | -62↓74.8% | -35↓32.7% | -27↓6.1% | -25 | |
| EPS (Basic) | -1.74↑27.2% | -2.39↓70.7% | -1.40↓30.8% | -1.07↓3.9% | -1.03 | |
| EPS (Diluted) | -1.74↑27.2% | -2.39↓70.7% | -1.40↓30.8% | -1.07↓3.9% | -1.03 | |
| Weighted Average Shares | 28↑7.6% | 26↑2.2% | 25↑1.3% | 25↑2.6% | 24 | |
| Weighted Average Diluted Shares | 28↑7.6% | 26↑2.2% | 25↑1.3% | 25↑2.6% | 24 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.